You are required to be logged in to access the full website
Click here if you have forgotten your username or password
13 October 2026 - Racura Oncology Limited (ASX:RAC), a late clinical-stage biopharmaceutical company, announced on Monday that the Safety Review Committee (SRC) for the Phase 1 HARNESS-1 trial has approved its lead oncology drug, RC220, to proceed to...
13 October 2026 - Blue Lake Biotechnology Inc, a clinical-stage intranasal vaccine company, on Monday reported the presentation of interim data from the company's Phase 1/2a paediatric clinical trial of RSV vaccine candidate BLB201 as a late-bre...
13 October 2026 - Commercial-stage biopharmaceutical company Shanghai Ark Biopharmaceutical Co Ltd ('ArkBio') announced on Monday that the US Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for ...
13 October 2026 - Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, said on Tuesday that it has entered into a research collaboration and licence agreeme...
13 October 2026 - Agilent Technologies Inc (NYSE:A), a provider of analytical and clinical laboratory technologies, announced on Tuesday that it has signed a definitive agreement to acquire Proscia, a provider of digital pathology software for clinic...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe